The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
The green tea polyphenol, epigallocatechin-3-gallate, inhibits hepatitis C virus entry
Open accessAbstract
Hepatitis C virus (HCV) is a major cause of liver cirrhosis and hepatocellular carcinoma. Current antiviral therapy fails to clear infection in a substantial proportion of cases. Drug development is focused on nonstructural proteins required for RNA replication. Individuals undergoing orthotopic liver transplantation face rapid, universal reinfection of the graft. Therefore, antiviral strategies targeting the early stages of infection are urgently needed for the prevention of HCV infection. In this study, we identified the polyphenol, epigallocatechin-3-gallate (EGCG), as an inhibitor of HCV entry. Green tea catechins, such as EGCG and its derivatives, epigallocatechin (EGC), epicatechin gallate (ECG), and epicatechin (EC), have been previously found to exert antiviral and antioncogenic properties. EGCG had no effect on HCV RNA replication, assembly, or release of progeny virions. However, it potently inhibited Cell-culture–derived HCV (HCVcc) entry into hepatoma cell lines as well as primary human hepatocytes. The effect was independent of the HCV genotype, and both infection of cells by extracellular virions and cell-to-cell spread were blocked. Pretreatment of cells with EGCG before HCV inoculation did not reduce HCV infection, whereas the application of EGCG during inoculation strongly inhibited HCV infectivity. Moreover, treatment with EGCG directly during inoculation strongly inhibited HCV infectivity. Expression levels of all known HCV (co-)receptors were unaltered by EGCG. Finally, we showed that EGCG inhibits viral attachment to the cell, thus disrupting the initial step of HCV cell entry. Conclusion: The green tea molecule, EGCG, potently inhibits HCV entry and could be part of an antiviral strategy aimed at the prevention of HCV reinfection after liver transplantation. (Hepatology 2011)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global epidemiology of hepatitis C virus infection
Shepard, C. W., Finelli, L., & Alter, M. J. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70216-4 · Cited by 2,758
Production of infectious hepatitis C virus in tissue culture from a cloned viral genome
Wakita, T., Pietschmann, T., Kato, T., Date, T., Miyamoto, M., Zhao, Z., Murthy, K., Habermann, A., Kräusslich, H.-G., Mizokami, M., et al. (2005) · Nature Medicine · doi:10.1038/nm1268 · Cited by 2,754
Self-citationComplete Replication of Hepatitis C Virus in Cell Culture
Lindenbach, B. D., Evans, M. J., Syder, A. J., Wölk, B., Tellinghuisen, T. L., Liu, C. C., Maruyama, T., Hynes, R. O., Burton, D. R., McKeating, J. A., et al. (2005) · Science · doi:10.1126/science.1114016 · Cited by 2,238
Robust hepatitis C virus infection in vitro
Zhong, J., Gastaminza, P., Cheng, G., Kapadia, S., Kato, T., Burton, D. R., Wieland, S. F., Uprichard, S. L., Wakita, T., & Chisari, F. V. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503596102 · Cited by 1,709
Pietschmann, T., Kaul, A., Koutsoudakis, G., Shavinskaya, A., Kallis, S., Steinmann, E., Abid, K., Negro, F., Dreux, M., Cosset, F.-L., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504877103 · Cited by 730
Self-citationLupberger, J., Zeisel, M. B., Xiao, F., Thumann, C., Fofana, I., Zona, L., Davis, C., Mee, C. J., Turek, M., Gorke, S., et al. (2011) · Nature Medicine · doi:10.1038/nm.2341 · Cited by 706
Self-citationChow, H.-H. S., Cai, Y., Hakim, I. A., Crowell, J. A., Shahi, F., Brooks, C. A., Dorr, R. T., Hara, Y., & Alberts, D. S. (2003) · PubMed · Cited by 706
Antiviral effect of catechins in green tea on influenza virus
Song, J.-M., Lee, K.-H., & Seong, B.-L. (2005) · Antiviral Research · doi:10.1016/j.antiviral.2005.06.010 · Cited by 654
Koutsoudakis, G., Kaul, A., Steinmann, E., Kallis, S., Lohmann, V., Pietschmann, T., & Bartenschlager, R. (2006) · Journal of Virology · doi:10.1128/jvi.02460-05 · Cited by 414
Self-citationReal-time imaging of hepatitis C virus infection using a fluorescent cell-based reporter system
Jones, C. T., Catanese, M. T., Law, L. M. J., Khetani, S. R., Syder, A. J., Ploss, A., Oh, T. S., Schoggins, J. W., MacDonald, M. R., Bhatia, S. N., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1604 · Cited by 249
Yamaguchi, K., Honda, M., Ikigai, H., Hara, Y., & Shimamura, T. (2002) · Antiviral Research · doi:10.1016/s0166-3542(01)00189-9 · Cited by 225
Inhibition of adenovirus infection and adenain by green tea catechins
Weber, J. M., Ruzindana-Umunyana, A., Imbeault, L., & Sircar, S. (2003) · Antiviral Research · doi:10.1016/s0166-3542(02)00212-7 · Cited by 225
Bankwitz, D., Steinmann, E., Bitzegeio, J., Ciesek, S., Friesland, M., Herrmann, E. M., Zeisel, M. B., Baumert, T. F., Keck, Z., Foung, S. K. H., et al. (2010) · Journal of Virology · doi:10.1128/jvi.02200-09 · Cited by 221
Self-citationNew cancer treatment strategy using combination of green tea catechins and anticancer drugs
Suganuma, M., Saha, A., & Fujiki, H. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2010.01805.x · Cited by 185
Hepatitis C virus entry into hepatocytes: Molecular mechanisms and targets for antiviral therapies
Zeisel, M. B., Fofana, I., Fafi-Kremer, S., & Baumert, T. F. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2010.10.014 · Cited by 184
Epigallocatechin Gallate Inactivates Clinical Isolates of Herpes Simplex Virus
Isaacs, C. E., Wen, G. Y., Xu, W., Jia, J. H., Rohan, L., Corbo, C., Di Maggio, V., Jenkins, E. C., & Hillier, S. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00825-07 · Cited by 183
Cyanovirin-N Inhibits Hepatitis C Virus Entry by Binding to Envelope Protein Glycans
Helle, F., Wychowski, C., Vu-Dac, N., Gustafson, K. R., Voisset, C., & Dubuisson, J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602431200 · Cited by 175
Rigid amphipathic fusion inhibitors, small molecule antiviral compounds against enveloped viruses
Vincent, M. S., Colpitts, C. C., Ustinov, A. V., Muqadas, M., Joyce, M., Barsby, N. L., Epand, R. F., Epand, R. M., Khramyshev, S. A., Valueva, O. A., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1010026107 · Cited by 156
Self-citationOxidized low-density lipoprotein inhibits hepatitis C virus cell entry in human hepatoma cells
von Hahn, T., Lindenbach, B. D., Boullier, A., Quehenberger, O., Paulson, M. S., Rice, C. M., & McKeating, J. A. (2006) · Hepatology · doi:10.1002/hep.21139 · Cited by 134
Epigallocatechin gallate inhibits HBV DNA synthesis in a viral replication - inducible cell line
He, W. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i11.1507 · Cited by 84
The dawn of a new era in HCV therapy
Ciesek, S., & Manns, M. P. (2011) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.219 · Cited by 60
Self-citationCiesek, S., Westhaus, S., Wicht, M., Wappler, I., Henschen, S., Sarrazin, C., Hamdi, N., Abdelaziz, A. I., Strassburg, C. P., Wedemeyer, H. H., et al. (2011) · Journal of Virology · doi:10.1128/jvi.00212-11 · Cited by 43
Self-citation
Cited by
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y.-J., Jiang, Q., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,304
Bioavailability of Dietary Polyphenols and Gut Microbiota Metabolism: Antimicrobial Properties
Marín, L., Miguélez, E. M., Villar, C. J., & Lombó, F. (2015) · BioMed Research International · doi:10.1155/2015/905215 · Cited by 776
Anti‐infective properties of epigallocatechin‐3‐gallate (EGCG), a component of green tea
Steinmann, J., Buer, J., Pietschmann, T., & Steinmann, E. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12009 · Cited by 559
Self-citationHuang, Q., Liu, X., Zhao, G., Hu, T., & Wang, Y. (2018) · Animal nutrition · doi:10.1016/j.aninu.2017.09.004 · Cited by 555
Antiviral Natural Products and Herbal Medicines
Lin, L.-T., Hsu, W.-C., & Lin, C.-C. (2014) · Journal of Traditional and Complementary Medicine · doi:10.4103/2225-4110.124335 · Cited by 529
Metadata
- Authors
- Ciesek, S., von Hahn, T., Colpitts, C. C., Schang, L. M., Friesland, M., Steinmann, J., Manns, M. P., Ott, M., Wedemeyer, H., Meuleman, P., Pietschmann, T., & Steinmann, E.
- Venue
- Hepatology
- Published
- 2010-12
- Volume
- 54
- Issue
- 6
- Pages
- 1947-1955
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2062378616
- Cited by
- 303
- References
- 22
- FWCI
- 9.22
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.